---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-025086"
form_type: "8-K"
ticker: "AXSM"
cik: "0001579428"
company_name: "Axsome Therapeutics, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:11:16.116068+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Axsome completes final closing of Sunosi acquisition from Jazz Pharmaceuticals on Nov 14, 2022

## Summary
- Final closing of ex-U.S. assets for Sunosi occurred Nov 14, 2022, satisfying closing conditions.
- Initial U.S. closing had occurred on May 9, 2022, as previously reported.
- Acquisition covers worldwide rights to Sunosi excluding 12 Asian markets (e.g., China, Korea, Japan).
- Financial statements and pro forma information were previously filed on July 21, 2022.

## SEC filing metadata
- accession: 0000950170-22-025086
- form_type: 8-K
- ticker: AXSM
- cik: 0001579428
- company_name: Axsome Therapeutics, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/0000950170-22-025086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/axsm-20221114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-025086
- JSON: https://secwatch.observer/filing/0000950170-22-025086.json
- Plain text: https://secwatch.observer/filing/0000950170-22-025086.txt

## Key facts
- M&A Transactions
  Axsome Therapeutics, Inc. completed an acquisition involving Jazz Pharmaceuticals plc (closed 2022-11-14).
  - Action: acquisition
  - Counterparty: Jazz Pharmaceuticals plc
  - Closing: 2022-11-14
  source text: The final closing contemplated by the Purchase Agreement (i.e., the conveyance of the ex-U.S. assets) occurred on November 14, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/0000950170-22-025086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
